Copyright Reports & Markets. All rights reserved.

Global Prescription Dermatology Therapeutics Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Prescription Dermatology Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Fungal Infection Drugs
    • 1.2.3 Skin Cancer Drugs
    • 1.2.4 Acne & Rosacea Drugs
    • 1.2.5 Psoriasis Drugs
    • 1.2.6 Dermatitis & Seborrhea Drugs
  • 1.3 Market by Application
    • 1.3.1 Global Prescription Dermatology Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Online Pharmacies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Prescription Dermatology Therapeutics Market Perspective (2016-2027)
  • 2.2 Prescription Dermatology Therapeutics Growth Trends by Regions
    • 2.2.1 Prescription Dermatology Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Prescription Dermatology Therapeutics Historic Market Share by Regions (2016-2021)
    • 2.2.3 Prescription Dermatology Therapeutics Forecasted Market Size by Regions (2022-2027)
  • 2.3 Prescription Dermatology Therapeutics Industry Dynamic
    • 2.3.1 Prescription Dermatology Therapeutics Market Trends
    • 2.3.2 Prescription Dermatology Therapeutics Market Drivers
    • 2.3.3 Prescription Dermatology Therapeutics Market Challenges
    • 2.3.4 Prescription Dermatology Therapeutics Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Prescription Dermatology Therapeutics Players by Revenue
    • 3.1.1 Global Top Prescription Dermatology Therapeutics Players by Revenue (2016-2021)
    • 3.1.2 Global Prescription Dermatology Therapeutics Revenue Market Share by Players (2016-2021)
  • 3.2 Global Prescription Dermatology Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Prescription Dermatology Therapeutics Revenue
  • 3.4 Global Prescription Dermatology Therapeutics Market Concentration Ratio
    • 3.4.1 Global Prescription Dermatology Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Prescription Dermatology Therapeutics Revenue in 2020
  • 3.5 Prescription Dermatology Therapeutics Key Players Head office and Area Served
  • 3.6 Key Players Prescription Dermatology Therapeutics Product Solution and Service
  • 3.7 Date of Enter into Prescription Dermatology Therapeutics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Prescription Dermatology Therapeutics Breakdown Data by Type

  • 4.1 Global Prescription Dermatology Therapeutics Historic Market Size by Type (2016-2021)
  • 4.2 Global Prescription Dermatology Therapeutics Forecasted Market Size by Type (2022-2027)

5 Prescription Dermatology Therapeutics Breakdown Data by Application

  • 5.1 Global Prescription Dermatology Therapeutics Historic Market Size by Application (2016-2021)
  • 5.2 Global Prescription Dermatology Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Prescription Dermatology Therapeutics Market Size (2016-2027)
  • 6.2 North America Prescription Dermatology Therapeutics Market Size by Type
    • 6.2.1 North America Prescription Dermatology Therapeutics Market Size by Type (2016-2021)
    • 6.2.2 North America Prescription Dermatology Therapeutics Market Size by Type (2022-2027)
    • 6.2.3 North America Prescription Dermatology Therapeutics Market Size by Type (2016-2027)
  • 6.3 North America Prescription Dermatology Therapeutics Market Size by Application
    • 6.3.1 North America Prescription Dermatology Therapeutics Market Size by Application (2016-2021)
    • 6.3.2 North America Prescription Dermatology Therapeutics Market Size by Application (2022-2027)
    • 6.3.3 North America Prescription Dermatology Therapeutics Market Size by Application (2016-2027)
  • 6.4 North America Prescription Dermatology Therapeutics Market Size by Country
    • 6.4.1 North America Prescription Dermatology Therapeutics Market Size by Country (2016-2021)
    • 6.4.2 North America Prescription Dermatology Therapeutics Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Prescription Dermatology Therapeutics Market Size (2016-2027)
  • 7.2 Europe Prescription Dermatology Therapeutics Market Size by Type
    • 7.2.1 Europe Prescription Dermatology Therapeutics Market Size by Type (2016-2021)
    • 7.2.2 Europe Prescription Dermatology Therapeutics Market Size by Type (2022-2027)
    • 7.2.3 Europe Prescription Dermatology Therapeutics Market Size by Type (2016-2027)
  • 7.3 Europe Prescription Dermatology Therapeutics Market Size by Application
    • 7.3.1 Europe Prescription Dermatology Therapeutics Market Size by Application (2016-2021)
    • 7.3.2 Europe Prescription Dermatology Therapeutics Market Size by Application (2022-2027)
    • 7.3.3 Europe Prescription Dermatology Therapeutics Market Size by Application (2016-2027)
  • 7.4 Europe Prescription Dermatology Therapeutics Market Size by Country
    • 7.4.1 Europe Prescription Dermatology Therapeutics Market Size by Country (2016-2021)
    • 7.4.2 Europe Prescription Dermatology Therapeutics Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Prescription Dermatology Therapeutics Market Size (2016-2027)
  • 8.2 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Type
    • 8.2.1 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Application
    • 8.3.1 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Region
    • 8.4.1 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Prescription Dermatology Therapeutics Market Size (2016-2027)
  • 9.2 Latin America Prescription Dermatology Therapeutics Market Size by Type
    • 9.2.1 Latin America Prescription Dermatology Therapeutics Market Size by Type (2016-2021)
    • 9.2.2 Latin America Prescription Dermatology Therapeutics Market Size by Type (2022-2027)
    • 9.2.3 Latin America Prescription Dermatology Therapeutics Market Size by Type (2016-2027)
  • 9.3 Latin America Prescription Dermatology Therapeutics Market Size by Application
    • 9.3.1 Latin America Prescription Dermatology Therapeutics Market Size by Application (2016-2021)
    • 9.3.2 Latin America Prescription Dermatology Therapeutics Market Size by Application (2022-2027)
    • 9.3.3 Latin America Prescription Dermatology Therapeutics Market Size by Application (2016-2027)
  • 9.4 Latin America Prescription Dermatology Therapeutics Market Size by Country
    • 9.4.1 Latin America Prescription Dermatology Therapeutics Market Size by Country (2016-2021)
    • 9.4.2 Latin America Prescription Dermatology Therapeutics Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Prescription Dermatology Therapeutics Market Size (2016-2027)
  • 10.2 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Type
    • 10.2.1 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Application
    • 10.3.1 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Country
    • 10.4.1 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Company Details
    • 11.1.2 Pfizer Business Overview
    • 11.1.3 Pfizer Prescription Dermatology Therapeutics Introduction
    • 11.1.4 Pfizer Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
    • 11.1.5 Pfizer Recent Development
  • 11.2 AbbVie
    • 11.2.1 AbbVie Company Details
    • 11.2.2 AbbVie Business Overview
    • 11.2.3 AbbVie Prescription Dermatology Therapeutics Introduction
    • 11.2.4 AbbVie Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
    • 11.2.5 AbbVie Recent Development
  • 11.3 Johnson & Johnson
    • 11.3.1 Johnson & Johnson Company Details
    • 11.3.2 Johnson & Johnson Business Overview
    • 11.3.3 Johnson & Johnson Prescription Dermatology Therapeutics Introduction
    • 11.3.4 Johnson & Johnson Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
    • 11.3.5 Johnson & Johnson Recent Development
  • 11.4 Novartis
    • 11.4.1 Novartis Company Details
    • 11.4.2 Novartis Business Overview
    • 11.4.3 Novartis Prescription Dermatology Therapeutics Introduction
    • 11.4.4 Novartis Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
    • 11.4.5 Novartis Recent Development
  • 11.5 Amgen
    • 11.5.1 Amgen Company Details
    • 11.5.2 Amgen Business Overview
    • 11.5.3 Amgen Prescription Dermatology Therapeutics Introduction
    • 11.5.4 Amgen Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
    • 11.5.5 Amgen Recent Development
  • 11.6 Eli Lilly
    • 11.6.1 Eli Lilly Company Details
    • 11.6.2 Eli Lilly Business Overview
    • 11.6.3 Eli Lilly Prescription Dermatology Therapeutics Introduction
    • 11.6.4 Eli Lilly Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
    • 11.6.5 Eli Lilly Recent Development
  • 11.7 Celgene
    • 11.7.1 Celgene Company Details
    • 11.7.2 Celgene Business Overview
    • 11.7.3 Celgene Prescription Dermatology Therapeutics Introduction
    • 11.7.4 Celgene Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
    • 11.7.5 Celgene Recent Development
  • 11.8 LEO Pharma
    • 11.8.1 LEO Pharma Company Details
    • 11.8.2 LEO Pharma Business Overview
    • 11.8.3 LEO Pharma Prescription Dermatology Therapeutics Introduction
    • 11.8.4 LEO Pharma Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
    • 11.8.5 LEO Pharma Recent Development
  • 11.9 Bausch Health Companies
    • 11.9.1 Bausch Health Companies Company Details
    • 11.9.2 Bausch Health Companies Business Overview
    • 11.9.3 Bausch Health Companies Prescription Dermatology Therapeutics Introduction
    • 11.9.4 Bausch Health Companies Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
    • 11.9.5 Bausch Health Companies Recent Development
  • 11.10 Sun Pharmaceutical
    • 11.10.1 Sun Pharmaceutical Company Details
    • 11.10.2 Sun Pharmaceutical Business Overview
    • 11.10.3 Sun Pharmaceutical Prescription Dermatology Therapeutics Introduction
    • 11.10.4 Sun Pharmaceutical Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
    • 11.10.5 Sun Pharmaceutical Recent Development
  • 11.11 Aclaris Therapeutics
    • 11.11.1 Aclaris Therapeutics Company Details
    • 11.11.2 Aclaris Therapeutics Business Overview
    • 11.11.3 Aclaris Therapeutics Prescription Dermatology Therapeutics Introduction
    • 11.11.4 Aclaris Therapeutics Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
    • 11.11.5 Aclaris Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Prescription Dermatology Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prescription Dermatology Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Fungal Infection Drugs
    Skin Cancer Drugs
    Acne & Rosacea Drugs
    Psoriasis Drugs
    Dermatitis & Seborrhea Drugs

    Segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Pfizer
    AbbVie
    Johnson & Johnson
    Novartis
    Amgen
    Eli Lilly
    Celgene
    LEO Pharma
    Bausch Health Companies
    Novartis

    Buy now